Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
About this item
Full title
Author / Creator
GIMEMA Investigators , Foà, Robin , Bassan, Renato , Vitale, Antonella , Elia, Loredana , Piciocchi, Alfonso , Puzzolo, Maria-Cristina , Canichella, Martina , Viero, Piera , Ferrara, Felicetto , Lunghi, Monia , Fabbiano, Francesco , Bonifacio, Massimiliano , Fracchiolla, Nicola , Di Bartolomeo, Paolo , Mancino, Alessandra , De Propris, Maria-Stefania , Vignetti, Marco , Guarini, Anna , Rambaldi, Alessandro and Chiaretti, Sabina
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In patients who have acute lymphoblastic leukemia with tumor cells that bear the Philadelphia chromosome, traditional therapy is not very effective. The use of the ABL kinase inhibitor dasatinib to achieve remission, followed by the bifunctional antibody blinatumomab (which has both anti-CD3 and anti-CD19 specificity as maintenance therapy), led to...
Alternative Titles
Full title
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Authors, Artists and Contributors
Author / Creator
Foà, Robin
Bassan, Renato
Vitale, Antonella
Elia, Loredana
Piciocchi, Alfonso
Puzzolo, Maria-Cristina
Canichella, Martina
Viero, Piera
Ferrara, Felicetto
Lunghi, Monia
Fabbiano, Francesco
Bonifacio, Massimiliano
Fracchiolla, Nicola
Di Bartolomeo, Paolo
Mancino, Alessandra
De Propris, Maria-Stefania
Vignetti, Marco
Guarini, Anna
Rambaldi, Alessandro
Chiaretti, Sabina
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2453158639
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2453158639
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2016272
